{"id":122,"date":"2017-03-29T21:09:20","date_gmt":"2017-03-29T21:09:20","guid":{"rendered":"http:\/\/34.138.3.201\/?page_id=122"},"modified":"2025-07-31T18:32:34","modified_gmt":"2025-07-31T18:32:34","slug":"dr-serge-gauthier","status":"publish","type":"page","link":"https:\/\/mcsa.ca\/index.php\/publications\/dr-serge-gauthier\/","title":{"rendered":"Dr. Serge Gauthier"},"content":{"rendered":"\n
    \n
  1. McCullough, A, Chen, CD, Gordon, BA, Joseph-Mathurin, N, Jack, CR Jr, Koeppe, R et al.<\/em>. Regional effects of gantenerumab on neuroimaging biomarkers in the DIAN-TU-001 trial. Alzheimers Dement. 2025;21 (7):e70347. doi: 10.1002\/alz.70347<\/a>. PubMed PMID:40660741<\/a> PubMed Central PMC12260115<\/a>.<\/li>\n\n\n\n
  2. Gagnon, A, Manns, BH, Atanasiu, K, Lumley, D, Chakravarty, M, Gauthier, S<\/strong> et al.<\/em>. The Neural Correlates of Delusions in Dementia: A Scoping Review. Psychogeriatrics. 2025;25 (4):e70060. doi: 10.1111\/psyg.70060<\/a>. PubMed PMID:40620111<\/a> .<\/li>\n\n\n\n
  3. Moscoso, A, Heeman, F, Raghavan, S, Costoya-S\u00e1nchez, A, van Essen, M, Mainta, I et al.<\/em>. Frequency and Clinical Outcomes Associated With Tau Positron Emission Tomography Positivity. JAMA. 2025;334 (3):229-242. doi: 10.1001\/jama.2025.7817<\/a>. PubMed PMID:40522652<\/a> .<\/li>\n\n\n\n
  4. Abbas, S, Ferreira, PCL, Bellaver, B, Povala, G, Rohden, F, Aguzzoli, CS et al.<\/em>. Utility of plasma GFAP as a secondary endpoint for clinical trials in Alzheimer’s disease. J Prev Alzheimers Dis. 2025;12 (7):100205. doi: 10.1016\/j.tjpad.2025.100205<\/a>. PubMed PMID:40473528<\/a> .<\/li>\n\n\n\n
  5. Chen, CD, Franklin, EE, Li, Y, Joseph-Mathurin, N, Burns, AL, Hobbs, DA et al.<\/em>. Immunohistochemical evaluation of a trial of gantenerumab or solanezumab in dominantly inherited Alzheimer disease. Acta Neuropathol. 2025;149 (1):57. doi: 10.1007\/s00401-025-02890-7<\/a>. PubMed PMID:40459787<\/a> PubMed Central PMC12133910<\/a>.<\/li>\n\n\n\n
  6. Bellaver, B, Povala, G, Ferreira, PCL, Bauer-Negrini, G, Lussier, FZ, Leffa, DT et al.<\/em>. Plasma GFAP for populational enrichment of clinical trials in preclinical Alzheimer’s disease. Alzheimers Dement. 2025;21 (5):e70209. doi: 10.1002\/alz.70209<\/a>. PubMed PMID:40346617<\/a> PubMed Central PMC12064411<\/a>.<\/li>\n\n\n\n
  7. Gauthier, S<\/strong>, Therriault, J, Rosa-Neto, P<\/strong>. Cholinergic therapy in Alzheimer disease. Handb Clin Neurol. 2025;211 :155-159. doi: 10.1016\/B978-0-443-19088-9.00015-9<\/a>. PubMed PMID:40340059<\/a> .<\/li>\n\n\n\n
  8. D\u00e9carie-Labb\u00e9, L, Mellah, S, Dialahy, IZ, CIMA-Q Consortium , Belleville, S. Predicting cognitive change using functional, structural, and neuropsychological predictors. Brain Commun. 2025;7 (3):fcaf155. doi: 10.1093\/braincomms\/fcaf155<\/a>. PubMed PMID:40337465<\/a> PubMed Central PMC12056721<\/a>.<\/li>\n\n\n\n
  9. Bezgin, G, Pascoal, TA, Therriault, J, Lussier, FZ, Servaes, S, Kang, MS et al.<\/em>. Tau profiling across Alzheimer’s disease staging reveals vulnerability to disease pathophysiology. Eur J Nucl Med Mol Imaging. 2025; :. doi: 10.1007\/s00259-025-07257-4<\/a>. PubMed PMID:40274672<\/a> .<\/li>\n\n\n\n
  10. Gauthier, S<\/strong>. Are Appropriate Use Recommendations useful in clinical practice?. J Prev Alzheimers Dis. 2025;12 (5):100165. doi: 10.1016\/j.tjpad.2025.100165<\/a>. PubMed PMID:40240188<\/a> PubMed Central PMC12184007<\/a>.<\/li>\n\n\n\n
  11. Aliaga, A, Therriault, J, Quispialaya, K, Aliaga, A, Kunach, P, Macedo, AC et al.<\/em>. Autoradiographic comparison between [11<\/sup>C]PiB and [18<\/sup>F]AZD4694 in human brain tissue. EJNMMI Res. 2025;15 (1):30. doi: 10.1186\/s13550-025-01216-8<\/a>. PubMed PMID:40167827<\/a> PubMed Central PMC11961831<\/a>.<\/li>\n\n\n\n
  12. Bateman, RJ, Li, Y, McDade, EM, Llibre-Guerra, JJ, Clifford, DB, Atri, A et al.<\/em>. Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer’s disease: an open-label extension of the phase 2\/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trial. Lancet Neurol. 2025;24 (4):316-330. doi: 10.1016\/S1474-4422(25)00024-9<\/a>. PubMed PMID:40120616<\/a> PubMed Central PMC12042767<\/a>.<\/li>\n\n\n\n
  13. Lantero-Rodriguez, J, Montoliu-Gaya, L, Ashton, NJ, Pola, I, Therriault, J, Rahmouni, N et al.<\/em>. Biofluid-based staging of Alzheimer’s disease. Acta Neuropathol. 2025;149 (1):27. doi: 10.1007\/s00401-025-02863-w<\/a>. PubMed PMID:40095069<\/a>PubMed Central PMC11913990<\/a>.<\/li>\n\n\n\n
  14. Tremblay, C, Rahayel, S, Pastor-Bernier, A, St-Onge, F, Vo, A, Rheault, F et al.<\/em>. Uncovering atrophy progression pattern and mechanisms in individuals at risk of Alzheimer’s disease. Brain Commun. 2025;7 (2):fcaf099. doi: 10.1093\/braincomms\/fcaf099<\/a>. PubMed PMID:40092368<\/a> PubMed Central PMC11906971<\/a>.<\/li>\n\n\n\n
  15. Heneka, MT, Gauthier, S<\/strong>, Chandekar, SA, Hviid Hahn-Pedersen, J, Bentsen, MA, Zetterberg, H et al.<\/em>. Neuroinflammatory fluid biomarkers in patients with Alzheimer’s disease: a systematic literature review. Mol Psychiatry. 2025;30 (6):2783-2798. doi: 10.1038\/s41380-025-02939-9<\/a>. PubMed PMID:40050444<\/a> PubMed Central PMC12092255<\/a>.<\/li>\n\n\n\n
  16. Bateman, RJ, Li, Y, McDade, EM, Llibre-Guerra, JJ, Clifford, DB, Atri, A et al.<\/em>. Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer’s disease: an open label extension of the phase 2\/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU Trial. medRxiv. 2025; :. doi: 10.1101\/2024.10.29.24316289<\/a>. PubMed PMID:39974075<\/a> PubMed Central PMC11838922<\/a>.<\/li>\n\n\n\n
  17. Arslan, B, Brum, WS, Pola, I, Therriault, J, Rahmouni, N, Stevenson, J et al.<\/em>. The impact of kidney function on Alzheimer’s disease blood biomarkers: implications for predicting amyloid-\u03b2 positivity. Alzheimers Res Ther. 2025;17 (1):48. doi: 10.1186\/s13195-025-01692-z<\/a>. PubMed PMID:39972340<\/a> PubMed Central PMC11837363<\/a>.<\/li>\n\n\n\n
  18. Yun, J, Shin, D, Lee, EH, Kim, JP, Ham, H, Gu, Y et al.<\/em>. Temporal Dynamics and Biological Variability of Alzheimer Biomarkers. JAMA Neurol. 2025;82 (4):384-96. doi: 10.1001\/jamaneurol.2024.5263<\/a>. PubMed PMID:39960728<\/a> PubMed Central PMC11833660<\/a>.<\/li>\n\n\n\n
  19. Sogorb-Esteve, A, Weiner, S, Simr\u00e9n, J, Swift, IJ, Bocchetta, M, Todd, EG et al.<\/em>. Proteomic analysis reveals distinct cerebrospinal fluid signatures across genetic frontotemporal dementia subtypes. Sci Transl Med. 2025;17 (784):eadm9654. doi: 10.1126\/scitranslmed.adm9654<\/a>. PubMed PMID:39908349<\/a> .<\/li>\n\n\n\n
  20. Wang, YT, Ashton, NJ, Therriault, J, Benedet, AL, Macedo, AC, Pola, I et al.<\/em>. Identify biological Alzheimer’s disease using a novel nucleic acid-linked protein immunoassay. Brain Commun. 2025;7 (1):fcaf004. doi: 10.1093\/braincomms\/fcaf004<\/a>. PubMed PMID:39845736<\/a> PubMed Central PMC11753389<\/a>.<\/li>\n\n\n\n
  21. D’Amico, D, Savundranayagam, MY, Biles, R, Itzhak, I, Anderson, ND, Canadian Consortium on Neurodegeneration in Aging (CCNA) CAN-THUMBS UP Study Group et al.<\/em>. Engaging older adults in the process of aging research: a multimethod study evaluating the experience and efficacy of a citizen advisory group for a dementia risk reduction program. Res Involv Engagem. 2024;10 (1):135. doi: 10.1186\/s40900-024-00643-6<\/a>. PubMed PMID:39731188<\/a> PubMed Central PMC11674478<\/a>.<\/li>\n\n\n\n
  22. Quispialaya, KM, Therriault, J, Aliaga, A, Benedet, AL, Ashton, NJ, Karikari, T et al.<\/em>. Comparison of Plasma p-tau217 and [18<\/sup>F]FDG-PET for Identifying Alzheimer Disease in People With Early-Onset or Atypical Dementia. Neurology. 2025;104 (2):e210211. doi: 10.1212\/WNL.0000000000210211<\/a>. PubMed PMID:39715476<\/a> PubMed Central PMC11666273<\/a>.<\/li>\n\n\n\n
  23. Chertkow, H, Phillips, N, Rockwood, K, Anderson, N, Andrew, MK, Bartha, R et al.<\/em>. Impact of a national dementia research consortium: The Canadian Consortium on Neurodegeneration in Aging (CCNA). J Alzheimers Dis. 2024;102 (3):535-561. doi: 10.1177\/13872877241290990<\/a>. PubMed PMID:39636028<\/a> .<\/li>\n\n\n\n
  24. Aumont, E, Bedard, MA, Bussy, A, Arias, JF, Tissot, C, Hall, BJ et al.<\/em>. Hippocampal atrophy over two years in relation to tau, amyloid-\u03b2 and memory in older adults. Neurobiol Aging. 2025;146 :48-57. doi: 10.1016\/j.neurobiolaging.2024.11.007<\/a>. PubMed PMID:39631245<\/a> .<\/li>\n\n\n\n
  25. Rojas-Rozo, L, Arsenault-Lapierre, G, Dumaresq, D, Tr\u00e9panier, T, Lea, P, Myers Barnett, K et al.<\/em>. Unlocking Engagement: Enhancing Participation in Research With Vulnerable Populations. Int J Public Health. 2024;69 :1606705. doi: 10.3389\/ijph.2024.1606705<\/a>. PubMed PMID:39568528<\/a> PubMed Central PMC11576723<\/a>.<\/li>\n\n\n\n
  26. Therriault, J, Janelidze, S, Benedet, AL, Ashton, NJ, Arranz Mart\u00ednez, J, Gonzalez-Escalante, A et al.<\/em>. Diagnosis of Alzheimer’s disease using plasma biomarkers adjusted to clinical probability. Nat Aging. 2024;4 (11):1529-1537. doi: 10.1038\/s43587-024-00731-y<\/a>. PubMed PMID:39533113<\/a> PubMed Central PMC11564087<\/a>.<\/li>\n\n\n\n
  27. Woo, MS, Therriault, J, Jonaitis, EM, Wilson, R, Langhough, RE, Rahmouni, N et al.<\/em>. Identification of late-stage tau accumulation using plasma phospho-tau217. EBioMedicine. 2024;109 :105413. doi: 10.1016\/j.ebiom.2024.105413<\/a>. PubMed PMID:39500009<\/a> PubMed Central PMC11570195<\/a>.<\/li>\n\n\n\n
  28. Aliaga, A, Therriault, J, Quispialaya, KM, Aliaga, A, Hopewell, R, Rahmouni, N et al.<\/em>. Comparison Between Brain and Cerebellar Autoradiography Using [18<\/sup>F]Flortaucipir, [18<\/sup>F]MK6240, and [18<\/sup>F]PI2620 in Postmortem Human Brain Tissue. J Nucl Med. 2025;66 (1):123-129. doi: 10.2967\/jnumed.124.267539<\/a>. PubMed PMID:39477493<\/a> .<\/li>\n\n\n\n
  29. Quispialaya, KM, Therriault, J, Aliaga, A, Tissot, C, Servaes, S, Rahmouni, N et al.<\/em>. Plasma phosphorylated tau181 outperforms [18<\/sup>F] fluorodeoxyglucose positron emission tomography in the identification of early Alzheimer disease. Eur J Neurol. 2024;31 (12):e16255. doi: 10.1111\/ene.16255<\/a>. PubMed PMID:39447157<\/a> PubMed Central PMC11555153<\/a>.<\/li>\n\n\n\n
  30. Meilleur-Durand, S, L\u00e9vesque, M, St-Onge, F, Masellis, M, Hsiung, GR, Jarrett, P et al.<\/em>. Multicenter Validation of the English Version of the D\u00e9pistage Cognitif de Qu\u00e9bec: a Cognitive Screening Tool for Atypical Dementias. Arch Clin Neuropsychol. 2025;40 (3):718-722. doi: 10.1093\/arclin\/acae092<\/a>. PubMed PMID:39394041<\/a> PubMed Central PMC12034515<\/a>.<\/li>\n\n\n\n
  31. Macedo, AC, Therriault, J, Tissot, C, Aumont, \u00c9, Servaes, S, Rahmouni, N et al.<\/em>. Modeling the progression of neuropsychiatric symptoms in Alzheimer’s disease with PET-based Braak staging. Neurobiol Aging. 2024;144 :127-137. doi: 10.1016\/j.neurobiolaging.2024.09.009<\/a>. PubMed PMID:39326302<\/a> .<\/li>\n\n\n\n
  32. Wiesman, AI, Madge, V, Fon, EA, Dagher, A, Collins, DL, Baillet, S et al.<\/em>. Associations between neuromelanin depletion and cortical rhythmic activity in Parkinson’s disease. Brain. 2025;148 (3):875-885. doi: 10.1093\/brain\/awae295<\/a>. PubMed PMID:39282945<\/a> PubMed Central PMC11884654<\/a>.<\/li>\n\n\n\n
  33. Belleville, S, Cuesta, M, Bier, N, Brodeur, C, Gauthier, S<\/strong>, Gilbert, B et al.<\/em>. Five-year effects of cognitive training in individuals with mild cognitive impairment. Alzheimers Dement (Amst). 2024;16 (3):e12626. doi: 10.1002\/dad2.12626<\/a>. PubMed PMID:39246830<\/a> PubMed Central PMC11378074<\/a>.<\/li>\n\n\n\n
  34. Bieger, A, Brum, WS, Borelli, WV, Therriault, J, De Bastiani, MA, Moreira, AG et al.<\/em>. Influence of Different Diagnostic Criteria on Alzheimer Disease Clinical Research. Neurology. 2024;103 (5):e209753. doi: 10.1212\/WNL.0000000000209753<\/a>. PubMed PMID:39167736<\/a> PubMed Central PMC11338500<\/a>.<\/li>\n\n\n\n
  35. Wang, YT, Therriault, J, Tissot, C, Servaes, S, Rahmouni, N, Macedo, AC et al.<\/em>. Hormone therapy is associated with lower Alzheimer’s disease tau biomarkers in post-menopausal females -evidence from two independent cohorts. Alzheimers Res Ther. 2024;16 (1):162. doi: 10.1186\/s13195-024-01509-5<\/a>. PubMed PMID:39034389<\/a> PubMed Central PMC11265084<\/a>.<\/li>\n\n\n\n
  36. Premi, E, Diano, M, Mattioli, I, Altomare, D, Cantoni, V, Bocchetta, M et al.<\/em>. Impaired glymphatic system in genetic frontotemporal dementia: a GENFI study. Brain Commun. 2024;6 (4):fcae185. doi: 10.1093\/braincomms\/fcae185<\/a>. PubMed PMID:39015769<\/a> PubMed Central PMC11249959<\/a>.<\/li>\n\n\n\n
  37. da Silva Castanheira, J, Wiesman, AI, Hansen, JY, Misic, B, Baillet, S, PREVENT-AD Research Group et al.<\/em>. The neurophysiological brain-fingerprint of Parkinson’s disease. EBioMedicine. 2024;105 :105201. doi: 10.1016\/j.ebiom.2024.105201<\/a>. PubMed PMID:38908100<\/a> PubMed Central PMC11253223<\/a>.<\/li>\n\n\n\n
  38. Ottoy, J, Kang, MS, Tan, JXM, Boone, L, Vos de Wael, R, Park, BY et al.<\/em>. Tau follows principal axes of functional and structural brain organization in Alzheimer’s disease. Nat Commun. 2024;15 (1):5031. doi: 10.1038\/s41467-024-49300-2<\/a>. PubMed PMID:38866759<\/a> PubMed Central PMC11169286<\/a>.<\/li>\n\n\n\n
  39. Howard, L, Abdelnour, C, Abner, EL, Allegri, RF, Dodge, HH, Gauthier, S<\/strong> et al.<\/em>. Decentralized clinical trials for medications to reduce the risk of dementia: Consensus report and guidance. Alzheimers Dement. 2024;20 (7):4625-4634. doi: 10.1002\/alz.13891<\/a>. PubMed PMID:38824659<\/a> PubMed Central PMC11247660<\/a>.<\/li>\n\n\n\n
  40. Wang, YT, Ashton, NJ, Servaes, S, Nilsson, J, Woo, MS, Pascoal, TA et al.<\/em>. The relation of synaptic biomarkers with A\u03b2, tau, glial activation, and neurodegeneration in Alzheimer’s disease. Transl Neurodegener. 2024;13 (1):27. doi: 10.1186\/s40035-024-00420-1<\/a>. PubMed PMID:38802928<\/a> PubMed Central PMC11131272<\/a>.<\/li>\n\n\n\n
  41. Wagemann, O, Liu, H, Wang, G, Shi, X, Bittner, T, Scelsi, MA et al.<\/em>. Downstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease: The DIAN-TU-001 Randomized Clinical Trial. JAMA Neurol. 2024;81 (6):582-593. doi: 10.1001\/jamaneurol.2024.0991<\/a>. PubMed PMID:38683602<\/a> PubMed Central PMC11059071<\/a>.<\/li>\n\n\n\n
  42. Walker, CS, Li, L, Baracchini, G, Tremblay-Mercier, J, Spreng, RN, PREVENT-AD Research Group et al.<\/em>. Neurobehavioral Mechanisms Influencing the Association Between Generativity, the Desire to Promote Well-Being of Younger Generations, and Purpose in Life in Older Adults at Risk for Alzheimer’s Disease. J Gerontol B Psychol Sci Soc Sci. 2024;79 (6):. doi: 10.1093\/geronb\/gbae060<\/a>. PubMed PMID:38623965<\/a> PubMed Central PMC11138215<\/a>.<\/li>\n\n\n\n
  43. Pasternak, M, Mirza, SS, Luciw, N, Mutsaerts, HJMM, Petr, J, Thomas, D et al.<\/em>. [Not Available]. Alzheimers Dement. 2024;20 (5):3525-3542. doi: 10.1002\/alz.13750<\/a>. PubMed PMID:38623902<\/a> PubMed Central PMC11095434<\/a>.<\/li>\n\n\n\n
  44. Samra, K, Peakman, G, MacDougall, AM, Bouzigues, A, Greaves, CV, Convery, RS et al.<\/em>. Extending the phenotypic spectrum assessed by the CDR plus NACC FTLD in genetic frontotemporal dementia. Alzheimers Dement (Amst). 2024;16 (2):e12571. doi: 10.1002\/dad2.12571<\/a>. PubMed PMID:38623386<\/a> PubMed Central PMC11016817<\/a>.<\/li>\n\n\n\n
  45. Macedo, AC, Therriault, J, Tissot, C, Fernandez-Arias, J, Ferreira, PCL, Vitali, P et al.<\/em>. Predicting functional decline in aging and Alzheimer’s disease with PET-based Braak staging. Brain Commun. 2024;6 (2):fcae043. doi: 10.1093\/braincomms\/fcae043<\/a>. PubMed PMID:38482373<\/a> PubMed Central PMC10935644<\/a>.<\/li>\n\n\n\n
  46. Therriault, J, Schindler, SE, Salvad\u00f3, G, Pascoal, TA, Benedet, AL, Ashton, NJ et al.<\/em>. Biomarker-based staging of Alzheimer disease: rationale and clinical applications. Nat Rev Neurol. 2024;20 (4):232-244. doi: 10.1038\/s41582-024-00942-2<\/a>. PubMed PMID:38429551<\/a> .<\/li>\n\n\n\n
  47. Frederiksen, KS, Morat\u00f3, X, Zetterberg, H, Gauthier, S<\/strong>, Boada, M, Pytel, V et al.<\/em>. Focusing on Earlier Management of Alzheimer Disease: Expert Opinion Based on a Modified Nominal Group Technique. Alzheimer Dis Assoc Disord. ;38 (1):1-7. doi: 10.1097\/WAD.0000000000000600<\/a>. PubMed PMID:38300883<\/a> .<\/li>\n\n\n\n
  48. Linnemann, C, Wilke, C, Mengel, D, Zetterberg, H, Heller, C, Kuhle, J et al.<\/em>. NfL reliability across laboratories, stage-dependent diagnostic performance and matrix comparability in genetic FTD: a large GENFI study. J Neurol Neurosurg Psychiatry. 2024;95 (9):822-828. doi: 10.1136\/jnnp-2023-332464<\/a>. PubMed PMID:38253362<\/a> PubMed Central PMC11347244<\/a>.<\/li>\n\n\n\n
  49. Benussi, A, Premi, E, Grassi, M, Alberici, A, Cantoni, V, Gazzina, S et al.<\/em>. Diagnostic accuracy of research criteria for prodromal frontotemporal dementia. Alzheimers Res Ther. 2024;16 (1):10. doi: 10.1186\/s13195-024-01383-1<\/a>. PubMed PMID:38216961<\/a> PubMed Central PMC10785469<\/a>.<\/li>\n\n\n\n
  50. Therriault, J, Woo, MS, Salvad\u00f3, G, Gobom, J, Karikari, TK, Janelidze, S et al.<\/em>. Comparison of immunoassay- with mass spectrometry-derived p-tau quantification for the detection of Alzheimer’s disease pathology. Mol Neurodegener. 2024;19 (1):2. doi: 10.1186\/s13024-023-00689-2<\/a>. PubMed PMID:38185677<\/a> PubMed Central PMC10773025<\/a>.<\/li>\n\n\n\n
  51. Frank, A, Ismail, Z, Wilson, M, Gauthier, S<\/strong>, Verret, L, Hsiung, GR et al.<\/em>. Health System Change for Alzheimer’s Disease-Modifying Therapies in Canada: Beginning the Discussion. Can J Neurol Sci. 2023; :1-9. doi: 10.1017\/cjn.2023.322<\/a>. PubMed PMID:38052729<\/a> .<\/li>\n\n\n\n
  52. Aumont, E, Bussy, A, Bedard, MA, Bezgin, G, Therriault, J, Savard, M et al.<\/em>. Hippocampal subfield associations with memory depend on stimulus modality and retrieval mode. Brain Commun. 2023;5 (6):fcad309. doi: 10.1093\/braincomms\/fcad309<\/a>. PubMed PMID:38035364<\/a> PubMed Central PMC10681971<\/a>.<\/li>\n\n\n\n
  53. Schaffer Aguzzoli, C, Ferreira, PCL, Povala, G, Ferrari-Souza, JP, Bellaver, B, Soares Katz, C et al.<\/em>. Neuropsychiatric Symptoms and Microglial Activation in Patients with Alzheimer Disease. JAMA Netw Open. 2023;6 (11):e2345175. doi: 10.1001\/jamanetworkopen.2023.45175<\/a>. PubMed PMID:38010651<\/a> PubMed Central PMC10682836<\/a>.<\/li>\n\n\n\n
  54. Woo, MS, Nilsson, J, Therriault, J, Rahmouni, N, Brinkmalm, A, Benedet, AL et al.<\/em>. 14-3-3 -reported early synaptic injury in Alzheimer’s disease is independently mediated by sTREM2. J Neuroinflammation. 2023;20 (1):278. doi: 10.1186\/s12974-023-02962-z<\/a>. PubMed PMID:38001539<\/a> PubMed Central PMC10675887<\/a>.<\/li>\n\n\n\n
  55. Quesnel, MJ, Labont\u00e9, A, Picard, C, Zetterberg, H, Blennow, K, Brinkmalm, A et al.<\/em>. Insulin-like growth factor binding protein-2 in at-risk adults and autopsy-confirmed Alzheimer brains. Brain. 2024;147 (5):1680-1695. doi: 10.1093\/brain\/awad398<\/a>. PubMed PMID:37992295<\/a> PubMed Central PMC11068109<\/a>.<\/li>\n\n\n\n
  56. Wang, YT, Therriault, J, Servaes, S, Tissot, C, Rahmouni, N, Macedo, AC et al.<\/em>. Sex-specific modulation of amyloid-\u03b2 on tau phosphorylation underlies faster tangle accumulation in females. Brain. 2024;147 (4):1497-1510. doi: 10.1093\/brain\/awad397<\/a>. PubMed PMID:37988283<\/a> PubMed Central PMC10994548<\/a>.<\/li>\n\n\n\n
  57. Ullgren, A, \u00d6ijerstedt, L, Olofsson, J, Bergstr\u00f6m, S, Remnest\u00e5l, J, van Swieten, JC et al.<\/em>. Altered plasma protein profiles in genetic FTD – a GENFI study. Mol Neurodegener. 2023;18 (1):85. doi: 10.1186\/s13024-023-00677-6<\/a>. PubMed PMID:37968725<\/a> PubMed Central PMC10648335<\/a>.<\/li>\n\n\n\n
  58. Parent, O, Bussy, A, Devenyi, GA, Dai, A, Costantino, M, Tullo, S et al.<\/em>. Assessment of white matter hyperintensity severity using multimodal magnetic resonance imaging. Brain Commun. 2023;5 (6):fcad279. doi: 10.1093\/braincomms\/fcad279<\/a>. PubMed PMID:37953840<\/a> PubMed Central PMC10636521<\/a>.<\/li>\n\n\n\n
  59. Woo, MS, Tissot, C, Lantero-Rodriguez, J, Snellman, A, Therriault, J, Rahmouni, N et al.<\/em>. Plasma pTau-217 and N-terminal tau (NTA) enhance sensitivity to identify tau PET positivity in amyloid-\u03b2 positive individuals. Alzheimers Dement. 2024;20 (2):1166-1174. doi: 10.1002\/alz.13528<\/a>. PubMed PMID:37920945<\/a> PubMed Central PMC10916953<\/a>.<\/li>\n\n\n\n
  60. Rojas-Rozo, L, Lee, L, Khanassov, V, Sivananthan, S, Ismail, Z, Gauthier, S<\/strong> et al.<\/em>. Latest Canadian Consensus Conference on the Diagnosis and Treatment of Dementia: What’s in It for Primary Care?. Can J Aging. 2024;43 (2):185-196. doi: 10.1017\/S0714980823000521<\/a>. PubMed PMID:37855225<\/a> .<\/li>\n\n\n\n
  61. Guilliot, S, Gauthier, S<\/strong>, Touchon, J, Soto, ME. Lithium, a Treatment Option for Alzheimer’s Disease? A Review of Existing Evidence and Discussion on Future Perspectives. J Alzheimers Dis. 2023;96 (2):473-482. doi: 10.3233\/JAD-230568<\/a>. PubMed PMID:37781804<\/a> .<\/li>\n\n\n\n
  62. Ferrari-Souza, JP, Bellaver, B, Ferreira, PCL, Benedet, AL, Povala, G, Lussier, FZ et al.<\/em>. APOE\u03b54 potentiates amyloid \u03b2 effects on longitudinal tau pathology. Nat Aging. 2023;3 (10):1210-1218. doi: 10.1038\/s43587-023-00490-2<\/a>. PubMed PMID:37749258<\/a> PubMed Central PMC10592050<\/a>.<\/li>\n\n\n\n
  63. Wittich, W, Kr\u00f6ger, E, Aubin, G, Fadhlaoui, A, Anderson, ND, Ben Gaied, N et al.<\/em>. Using co-creation focus groups to customise a remote multidomain programme designed to increase dementia literacy. BMJ Open. 2023;13 (9):e074555. doi: 10.1136\/bmjopen-2023-074555<\/a>. PubMed PMID:37709333<\/a> PubMed Central PMC10921908<\/a>.<\/li>\n\n\n\n
  64. Gauthier, S<\/strong>. Can we improve care of people with mild cognitive impairment or dementia in Canada?. Can J Neurol Sci. 2023; :1-3. doi: 10.1017\/cjn.2023.283<\/a>. PubMed PMID:37655739<\/a> .<\/li>\n\n\n\n
  65. Wang, YT, Rosa-Neto, P<\/strong>, Gauthier, S<\/strong>. Advanced brain imaging for the diagnosis of Alzheimer disease. Curr Opin Neurol. 2023;36 (5):481-490. doi: 10.1097\/WCO.0000000000001198<\/a>. PubMed PMID:37639461<\/a> .<\/li>\n\n\n\n
  66. Cinalioglu, K, Lav\u00edn, P, Bein, M, Lesage, M, Gruber, J, Se, J et al.<\/em>. Effects of virtual reality guided meditation in older adults: the protocol of a pilot randomized controlled trial. Front Psychol. 2023;14 :1083219. doi: 10.3389\/fpsyg.2023.1083219<\/a>. PubMed PMID:37575420<\/a> PubMed Central PMC10421698<\/a>.<\/li>\n\n\n\n
  67. Ferreira, PCL, Therriault, J, Tissot, C, Ferrari-Souza, JP, Benedet, AL, Povala, G et al.<\/em>. Plasma p-tau231 and p-tau217 inform on tau tangles aggregation in cognitively impaired individuals. Alzheimers Dement. 2023;19 (10):4463-4474. doi: 10.1002\/alz.13393<\/a>. PubMed PMID:37534889<\/a> PubMed Central PMC10592380<\/a>.<\/li>\n\n\n\n
  68. Samra, K, MacDougall, AM, Bouzigues, A, Bocchetta, M, Cash, DM, Greaves, CV et al.<\/em>. Prodromal language impairment in genetic frontotemporal dementia within the GENFI cohort. J Neurol Sci. 2023;451 :120711. doi: 10.1016\/j.jns.2023.120711<\/a>. PubMed PMID:37348248<\/a> .<\/li>\n\n\n\n
  69. Macedo, AC, Tissot, C, Therriault, J, Servaes, S, Wang, YT, Fernandez-Arias, J et al.<\/em>. The Use of Tau PET to Stage Alzheimer Disease According to the Braak Staging Framework. J Nucl Med. 2023;64 (8):1171-1178. doi: 10.2967\/jnumed.122.265200<\/a>. PubMed PMID:37321820<\/a> PubMed Central PMC10394315<\/a>.<\/li>\n\n\n\n
  70. Fern\u00e1ndez Arias, J, Therriault, J, Thomas, E, Lussier, FZ, Bezgin, G, Tissot, C et al.<\/em>. Verbal memory formation across PET-based Braak stages of tau accumulation in Alzheimer’s disease. Brain Commun. 2023;5 (3):fcad146. doi: 10.1093\/braincomms\/fcad146<\/a>. PubMed PMID:37252014<\/a> PubMed Central PMC10213301<\/a>.<\/li>\n\n\n\n
  71. Bellaver, B, Povala, G, Ferreira, PCL, Ferrari-Souza, JP, Leffa, DT, Lussier, FZ et al.<\/em>. Astrocyte reactivity influences amyloid-\u03b2 effects on tau pathology in preclinical Alzheimer’s disease. Nat Med. 2023;29 (7):1775-1781. doi: 10.1038\/s41591-023-02380-x<\/a>. PubMed PMID:37248300<\/a> PubMed Central PMC10353939<\/a>.<\/li>\n\n\n\n
  72. Ai, M, Morris, TP, Zhang, J, de la Colina, AN, Tremblay-Mercier, J, Villeneuve, S et al.<\/em>. Resting-state MRI functional connectivity as a neural correlate of multidomain lifestyle adherence in older adults at risk for Alzheimer’s disease. Sci Rep. 2023;13 (1):7487. doi: 10.1038\/s41598-023-32714-1<\/a>. PubMed PMID:37160915<\/a> PubMed Central PMC10170147<\/a>.<\/li>\n\n\n\n
  73. Therriault, J, Pascoal, TA, Lussier, FZ, Tissot, C, Chamoun, M, Bezgin, G et al.<\/em>. Biomarker modeling of Alzheimer’s disease using PET-based Braak staging. Nat Aging. 2022;2 (6):526-535. doi: 10.1038\/s43587-022-00204-0<\/a>. PubMed PMID:37118445<\/a> PubMed Central PMC10154209<\/a>.<\/li>\n\n\n\n
  74. Therriault, J, Servaes, S, Tissot, C, Rahmouni, N, Ashton, NJ, Benedet, AL et al.<\/em>. Equivalence of plasma p-tau217 with cerebrospinal fluid in the diagnosis of Alzheimer’s disease. Alzheimers Dement. 2023;19 (11):4967-4977. doi: 10.1002\/alz.13026<\/a>. PubMed PMID:37078495<\/a> PubMed Central PMC10587362<\/a>.<\/li>\n\n\n\n
  75. Ferrari-Souza, JP, Lussier, FZ, Leffa, DT, Therriault, J, Tissot, C, Bellaver, B et al.<\/em>. APOE<\/em>\u03b54 associates with microglial activation independently of A\u03b2 plaques and tau tangles. Sci Adv. 2023;9 (14):eade1474. doi: 10.1126\/sciadv.ade1474<\/a>. PubMed PMID:37018391<\/a> PubMed Central PMC10075966<\/a>.<\/li>\n\n\n\n
  76. Chen, CD, McCullough, A, Gordon, B, Joseph-Mathurin, N, Flores, S, McKay, NS et al.<\/em>. Longitudinal head-to-head comparison of 11<\/sup>C-PiB and 18<\/sup>F-florbetapir PET in a Phase 2\/3 clinical trial of anti-amyloid-\u03b2 monoclonal antibodies in dominantly inherited Alzheimer’s disease. Eur J Nucl Med Mol Imaging. 2023;50 (9):2669-2682. doi: 10.1007\/s00259-023-06209-0<\/a>. PubMed PMID:37017737<\/a> PubMed Central PMC10330155<\/a>.<\/li>\n\n\n\n
  77. Bocchetta, M, Todd, EG, Bouzigues, A, Cash, DM, Nicholas, JM, Convery, RS et al.<\/em>. Structural MRI predicts clinical progression in presymptomatic genetic frontotemporal dementia: findings from the GENetic Frontotemporal dementia Initiative cohort. Brain Commun. 2023;5 (2):fcad061. doi: 10.1093\/braincomms\/fcad061<\/a>. PubMed PMID:36970046<\/a> PubMed Central PMC10036293<\/a>.<\/li>\n\n\n\n
  78. Samra, K, MacDougall, AM, Bouzigues, A, Bocchetta, M, Cash, DM, Greaves, CV et al.<\/em>. Genetic forms of primary progressive aphasia within the GENetic Frontotemporal dementia Initiative (GENFI) cohort: comparison with sporadic primary progressive aphasia. Brain Commun. 2023;5 (2):fcad036. doi: 10.1093\/braincomms\/fcad036<\/a>. PubMed PMID:36938528<\/a> PubMed Central PMC10019761<\/a>.<\/li>\n\n\n\n
  79. Bellaver, B, Puig-Pijoan, A, Ferrari-Souza, JP, Leffa, DT, Lussier, FZ, Ferreira, PCL et al.<\/em>. Blood-brain barrier integrity impacts the use of plasma amyloid-\u03b2 as a proxy of brain amyloid-\u03b2 pathology. Alzheimers Dement. 2023;19 (9):3815-3825. doi: 10.1002\/alz.13014<\/a>. PubMed PMID:36919582<\/a> PubMed Central PMC10502181<\/a>.<\/li>\n\n\n\n
  80. Premi, E, Pengo, M, Mattioli, I, Cantoni, V, Dukart, J, Gasparotti, R et al.<\/em>. Early neurotransmitters changes in prodromal frontotemporal dementia: A GENFI study. Neurobiol Dis. 2023;179 :106068. doi: 10.1016\/j.nbd.2023.106068<\/a>. PubMed PMID:36898614<\/a> .<\/li>\n\n\n\n
  81. Bussy, A, Levy, JP, Best, T, Patel, R, Cupo, L, Van Langenhove, T et al.<\/em>. Cerebellar and subcortical atrophy contribute to psychiatric symptoms in frontotemporal dementia. Hum Brain Mapp. 2023;44 (7):2684-2700. doi: 10.1002\/hbm.26220<\/a>. PubMed PMID:36895129<\/a> PubMed Central PMC10089095<\/a>.<\/li>\n\n\n\n
  82. Ferreira, PCL, Ferrari-Souza, JP, Tissot, C, Bellaver, B, Leffa, DT, Lussier, F et al.<\/em>. Potential Utility of Plasma P-Tau and Neurofilament Light Chain as Surrogate Biomarkers for Preventive Clinical Trials. Neurology. 2023;101 (1):38-45. doi: 10.1212\/WNL.0000000000207115<\/a>. PubMed PMID:36878697<\/a> PubMed Central PMC10351303<\/a>.<\/li>\n\n\n\n
  83. Tedeschi Dauar, M, Pascoal, TA, Therriault, J, Rowley, J, Mohaddes, S, Shin, M et al.<\/em>. Dynamic Amyloid and Metabolic Signatures of Delayed Recall Performance within the Clinical Spectrum of Alzheimer’s Disease. Brain Sci. 2023;13 (2):. doi: 10.3390\/brainsci13020232<\/a>. PubMed PMID:36831775<\/a> PubMed Central PMC9954101<\/a>.<\/li>\n\n\n\n
  84. Intzandt, B, Sanami, S, Huck, J, PREVENT-AD Research group, Villeneuve, S, Bherer, L et al.<\/em>. Sex-specific relationships between obesity, physical activity, and gray and white matter volume in cognitively unimpaired older adults. Geroscience. 2023;45 (3):1869-1888. doi: 10.1007\/s11357-023-00734-4<\/a>. PubMed PMID:36781598<\/a> PubMed Central PMC10400512<\/a>.<\/li>\n\n\n\n
  85. Pascoal, T, Bellaver, B, Povala, G, Ferreira, P, Ferrari-Souza, JP, Leffa, D et al.<\/em>. Astrocyte reactivity influences the association of amyloid-\u03b2 and tau biomarkers in preclinical Alzheimer’s disease. Res Sq. 2023; :. doi: 10.21203\/rs.3.rs-2507179\/v1<\/a>. PubMed PMID:36778243<\/a> PubMed Central PMC9915798<\/a>.<\/li>\n\n\n\n
  86. Pascoal, TA, Leuzy, A, Therriault, J, Chamoun, M, Lussier, F, Tissot, C et al.<\/em>. Discriminative accuracy of the A\/T\/N scheme to identify cognitive impairment due to Alzheimer’s disease. Alzheimers Dement (Amst). 2023;15 (1):e12390. doi: 10.1002\/dad2.12390<\/a>. PubMed PMID:36733847<\/a> PubMed Central PMC9886860<\/a>.<\/li>\n\n\n\n
  87. Jia, J, Zhao, T, Liu, Z, Liang, Y, Li, F, Li, Y et al.<\/em>. Association between healthy lifestyle and memory decline in older adults: 10 year, population based, prospective cohort study. BMJ. 2023;380 :e072691. doi: 10.1136\/bmj-2022-072691<\/a>. PubMed PMID:36696990<\/a> PubMed Central PMC9872850<\/a>.<\/li>\n\n\n\n
  88. Kwan, ATH, Arfaie, S, Therriault, J, Azizi, Z, Lussier, FZ, Tissot, C et al.<\/em>. Medial temporal tau predicts memory decline in cognitively unimpaired elderly. Brain Commun. 2023;5 (1):fcac325. doi: 10.1093\/braincomms\/fcac325<\/a>. PubMed PMID:36627889<\/a> PubMed Central PMC9814120<\/a>.<\/li>\n\n\n\n
  89. Samra, K, Macdougall, A, Peakman, G, Bouzigues, A, Bocchetta, M, Cash, DM et al.<\/em>. Neuropsychiatric symptoms in genetic frontotemporal dementia: developing a new module for Clinical Rating Scales. J Neurol Neurosurg Psychiatry. 2023;94 (5):357-368. doi: 10.1136\/jnnp-2022-330152<\/a>. PubMed PMID:36627201<\/a> PubMed Central PMC10176351<\/a>.<\/li>\n\n\n\n
  90. Therriault, J, Gauthier, S<\/strong>, Rosa-Neto, P<\/strong>. Applications of Alzheimer’s disease staging to clinical trials. Aging (Albany NY). 2023;15 (1):4-5. doi: 10.18632\/aging.204482<\/a>. PubMed PMID:36622284<\/a> PubMed Central PMC9876645<\/a>.<\/li>\n\n\n\n
  91. Liu, W, Gauthier, S<\/strong>, Jia, J. Alzheimer’s disease: current status and perspective. Sci Bull (Beijing). 2022;67 (24):2494-2497. doi: 10.1016\/j.scib.2022.12.006<\/a>. PubMed PMID:36604022<\/a> .<\/li>\n\n\n\n
  92. Samra, K, MacDougall, AM, Bouzigues, A, Bocchetta, M, Cash, DM, Greaves, CV et al.<\/em>. Language impairment in the genetic forms of behavioural variant frontotemporal dementia. J Neurol. 2023;270 (4):1976-1988. doi: 10.1007\/s00415-022-11512-1<\/a>. PubMed PMID:36538154<\/a> PubMed Central PMC10025186<\/a>.<\/li>\n\n\n\n
  93. Therriault, J, Vermeiren, M, Servaes, S, Tissot, C, Ashton, NJ, Benedet, AL et al.<\/em>. Association of Phosphorylated Tau Biomarkers With Amyloid Positron Emission Tomography vs Tau Positron Emission Tomography. JAMA Neurol. 2023;80 (2):188-199. doi: 10.1001\/jamaneurol.2022.4485<\/a>. PubMed PMID:36508198<\/a> PubMed Central PMC9856704<\/a>.<\/li>\n\n\n\n
  94. Finger, E, Malik, R, Bocchetta, M, Coleman, K, Graff, C, Borroni, B et al.<\/em>. Neurodevelopmental effects of genetic frontotemporal dementia in young adult mutation carriers. Brain. 2023;146 (5):2120-2131. doi: 10.1093\/brain\/awac446<\/a>. PubMed PMID:36458975<\/a> .<\/li>\n\n\n\n
  95. Grazia, A, Altomare, D, Preis, L, Monsch, AU, Cappa, SF, Gauthier, S<\/strong> et al.<\/em>. Feasibility of a standard cognitive assessment in European academic memory clinics. Alzheimers Dement. 2023;19 (6):2276-2286. doi: 10.1002\/alz.12830<\/a>. PubMed PMID:36453876<\/a> .<\/li>\n\n\n\n
  96. P\u00e9rez-Millan, A, Borrego-\u00c9cija, S, van Swieten, JC, Jiskoot, L, Moreno, F, Laforce, R et al.<\/em>. Loss of brainstem white matter predicts onset and motor neuron symptoms in C9orf72 expansion carriers: a GENFI study. J Neurol. 2023;270 (3):1573-1586. doi: 10.1007\/s00415-022-11435-x<\/a>. PubMed PMID:36443488<\/a> .<\/li>\n\n\n\n
  97. Iturria-Medina, Y, Adewale, Q, Khan, AF, Ducharme, S, Rosa-Neto, P<\/strong>, O’Donnell, K et al.<\/em>. Unified epigenomic, transcriptomic, proteomic, and metabolomic taxonomy of Alzheimer’s disease progression and heterogeneity. Sci Adv. 2022;8 (46):eabo6764. doi: 10.1126\/sciadv.abo6764<\/a>. PubMed PMID:36399579<\/a> PubMed Central PMC9674284<\/a>.<\/li>\n\n\n\n
  98. Tissot, C, Servaes, S, Lussier, FZ, Ferrari-Souza, JP, Therriault, J, Ferreira, PCL et al.<\/em>. The Association of Age-Related and Off-Target Retention with Longitudinal Quantification of [18<\/sup>F]MK6240 Tau PET in Target Regions. J Nucl Med. 2023;64 (3):452-459. doi: 10.2967\/jnumed.122.264434<\/a>. PubMed PMID:36396455<\/a> PubMed Central PMC10071794<\/a>.<\/li>\n\n\n\n
  99. Samra, K, MacDougall, AM, Peakman, G, Bouzigues, A, Bocchetta, M, Cash, DM et al.<\/em>. Motor symptoms in genetic frontotemporal dementia: developing a new module for clinical rating scales. J Neurol. 2023;270 (3):1466-1477. doi: 10.1007\/s00415-022-11442-y<\/a>. PubMed PMID:36385202<\/a> PubMed Central PMC9971048<\/a>.<\/li>\n\n\n\n
  100. Whiteside, DJ, Malpetti, M, Jones, PS, Ghosh, BCP, Coyle-Gilchrist, I, van Swieten, JC et al.<\/em>. Temporal dynamics predict symptom onset and cognitive decline in familial frontotemporal dementia. Alzheimers Dement. 2023;19 (5):1947-1962. doi: 10.1002\/alz.12824<\/a>. PubMed PMID:36377606<\/a> PubMed Central PMC7614527<\/a>.<\/li>\n<\/ol>\n\n\n\n

    Search PubMed<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

    Search PubMed<\/p>\n","protected":false},"author":6,"featured_media":0,"parent":71,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"_links":{"self":[{"href":"https:\/\/mcsa.ca\/index.php\/wp-json\/wp\/v2\/pages\/122"}],"collection":[{"href":"https:\/\/mcsa.ca\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/mcsa.ca\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/mcsa.ca\/index.php\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/mcsa.ca\/index.php\/wp-json\/wp\/v2\/comments?post=122"}],"version-history":[{"count":4,"href":"https:\/\/mcsa.ca\/index.php\/wp-json\/wp\/v2\/pages\/122\/revisions"}],"predecessor-version":[{"id":3879,"href":"https:\/\/mcsa.ca\/index.php\/wp-json\/wp\/v2\/pages\/122\/revisions\/3879"}],"up":[{"embeddable":true,"href":"https:\/\/mcsa.ca\/index.php\/wp-json\/wp\/v2\/pages\/71"}],"wp:attachment":[{"href":"https:\/\/mcsa.ca\/index.php\/wp-json\/wp\/v2\/media?parent=122"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}